FDA Adverse Event Malfunction Summary report: N

OMNIPOD INSULIN PUMP

MDR report key: 2962062 · Received January 24, 2013

Report

Report Number
3004464228-2013-00065
Event Type
Malfunction
Date Received
January 24, 2013
Date of Event
December 28, 2012
Report Date
December 28, 2012
Manufacturer
INSULET CORPORATION
Product Code
LZG
PMA / PMN Number
K042792
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

THE RETURNED PRODUCT WAS EVALUATED AND THE REPORTED MALFUNCTION WAS CONFIRMED. ITS ROOT CAUSE WAS DETERMINED TO BE AN ASSEMBLY ERROR. THE RELEASE BAR WAS INCORRECTLY INSTALLED. AN INVESTIGATION INTO THIS ISSUE WAS CONDUCTED AND MANUFACTURING WORK INSTRUCTIONS AND TRAINING PROCEDURES WERE UPDATED. QUALIFICATION RECORDS WERE REVIEWED AND THE PRODUCT LOT MET ALL ACCEPTANCE CRITERIA. THE OMNIPOD'S USER GUIDE WARNS TO "CHECK THE INFUSION SITE AFTER INSERTION TO ENSURE THAT THE CANNULA WAS PROPERLY INSERTED. IT IS ALSO A GOOD IDEA TO CHECK YOUR BLOOD GLUCOSE ABOUT TWO HOURS AFTER EACH POD CHANGE AND TO CHECK THE INFUSION SITE PERIODICALLY. IF THE CANNULA IS NOT PROPERLY INSERTED, HYPERGLYCEMIA MAY RESULT." "TEST RESULTS GREATER THAN 250 MG/DL MEAN HIGH BLOOD GLUCOSE (HYPERGLYCEMIA). IF YOU GET RESULTS ABOVE 250 MG/DL, BUT DO NOT HAVE SYMPTOMS OF HYPERGLYCEMIA, REPEAT THE TEST. IF YOU HAVE SYMPTOMS OR CONTINUE TO GET RESULTS THAT FALL ABOVE 250 MG/DL, FOLLOW THE TREATMENT ADVICE OF YOUR HEALTHCARE PROVIDER."

Description of Event or Problem · 1

THE CUSTOMER CALLED TO REPORT THE NEEDLE MECHANISM FAILED TO INSERT THE CANNULA INTO THE INFUSION SITE AND HIS HIGH BLOOD GLUCOSE REACHED 290 MG/DL.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
34898 OMNIPOD INSULIN PUMP PUMP, INFUSION, INSULIN LZG INSULET CORPORATION 11200 L30937

Patients

Seq Age Sex Outcome Treatment
1 42 YR